Impaired p53 function appears critical to reveal the pro-tumorigenic effects of centrosome amplification downstream of Plk4 overexpression across all animal models tested so far (21, 22, 24), but none of those studies introduced oncogenic drivers or IR as alternative tumor-promoting events. This evidence concerns the gene TP53 and neoplasm.